SOURCE 3 post-approval registry—One-year outcomes in 1,946 TAVI patients with a 3rd generation balloon transcatheter heart valve
Sponsored by Edwards Lifesciences
Speaker: O. Wendler
- At 1 year, patients treated via the transfemoral access route had a high survival rate (88.2 percent) and a low disabling stroke rate (1.1 percent).
- Patients experienced a low rate (2.7 percent) of moderate paravalvular leak and no severe paravalvular leak.
Page published on August 2017